Flagship Pioneering Forms Etcelera to Move Drug Discovery from Probability to PredictionEtcelera unites the platform technologies of Cellarity, Etiome, and Empress Therapeutics with Flagship Pioneering's proprietary AI capabilities to scale causal intelligence in human biologyPR Newswire Business Technology · 2026-10-29T10:30:00.000Z